Preparing for a maternal GBS vaccine in Africa
Part of Infections clinical trials.
This study is preparing for future trials of a vaccine for Group B Strep (GBS) in pregnant women. It includes different parts: watching pregnant women and their babies, surveying GBS infections, and understanding how communities feel about vaccines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a pregnant woman or new mother receiving care at a participating hospital in Uganda, Malawi, Mozambique, or Kenya.
- Your baby is under 90 days old and has a lab-confirmed GBS infection (for the GBS surveillance part).
- You are able to give written informed consent (or your parent/guardian can for your baby).
- You live in the area near the participating health facility.
- You are 18 or older (16 in Malawi for emancipated minors) if joining the vaccine confidence part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information about the health and outcomes of babies and children who had a serious Group B Strep infection around birth. It aims to better understand the long-term effects and improve care for families impacted by this infection.
This study tests a vaccine against Group B Streptococcus (GBS) during pregnancy to see if it can protect newborns from infection. Healthy pregnant women with a single baby can join.
This study tests blood samples from women who received a Group B Streptococcus (GBS) vaccine during pregnancy to ensure the vaccine is working safely and correctly. Researchers want to check your immune response and confirm the vaccine quality.
This Phase 3 study tests whether MTBVAC can safely protect newborn babies from tuberculosis and whether it helps the baby’s immune system learn to fight TB. If you enroll, the goal is to see safety and immune response in real newborn settings in sub-Saharan Africa.
This early-phase study looks at whether swabbing a mother’s vagina during a planned C-section (“vaginal seeding”) can help shape a newborn’s early respiratory and gut microbes. The goal is to see if this approach is safe and may influence early-life breathing health.
This trial tests whether giving measles and BCG vaccines to mothers and their children after the child turns 12 months is safe and helpful. It specifically looks at women who are not pregnant and meet several health and study-area requirements.
Hear when a new Group B Streptococcus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.